Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI 907828 |
Trade Name | |
Synonyms | BI907828|BI-907828|Brigimadlin |
Drug Descriptions |
BI 907828 is an MDM2 inhibitor that potentially inhibits tumor growth and improves anti-tumor immunity (PMID: 31201607; Cancer Res 2018;78(13 Suppl):Abstract nr 4866). |
DrugClasses | MDM2 Inhibitor 23 |
CAS Registry Number | 2095116-40-6 |
NCIT ID | C156709 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI 907828 | BI 907828 | 3 | 5 |
BI 907828 + Ezabenlimab | BI 907828 Ezabenlimab | 1 | 2 |
BI 907828 + Ezabenlimab + Miptenalimab | BI 907828 Ezabenlimab Miptenalimab | 0 | 1 |
BI 907828 + Rifampin | BI 907828 Rifampin | 0 | 0 |